Inventor

Zhi Liu

Inventor
Seattle, WA, US

Overview

20→
Patents
1998–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides16%
C12NMicroorganisms or enzymes10%
Y10TTechnical subjects covered by former us classification7%
B01DSeparation5%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry5%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
C12YEnzymes2%
PatentTitleYear
10,525,150Targeted contrast agents and methods for targeting contrast agents202010,233,237Heterodimeric immunoglobulins201910,213,493Protein to promote blood vessel growth and uses thereof20199,822,173'Heterodimeric immunoglobulins'20179,675,688'Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same'20179,339,559'Targeted contrast agents and methods for targeting contrast agents'20169,175,063'Anti-angiogenic agent and methods of using such agent'20159,138,473'Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same'20158,697,648'Protein agent for diabetes treatment and β cell imaging'20148,524,829'Methods for micronization of hydrophobic drugs'20138,367,040'Contrast agents and methods for preparing contrast agents'20138,197,824'Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same'20128,173,105'Contrast agents and methods for preparing contrast agents'20127,741,066'Phosphorylated p68 RNA helicase as a marker for cancer and cancer metastasis'20107,666,434'Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same'20107,431,934'Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same'20087,078,041'Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same'20066,824,791'Methods for micronization of hydrophobic drugs'20046,746,635'Methods for micronization of hydrophobic drugs'20045,811,307'Dicationic perylene dye for precipitation and quantitation of DNA'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2013Patents assigned to UNIV BROWN RES FOUND (3)· patent assignee history
2004Based in West Roxbury, MA, US· patent location history
2006–2017Patents assigned to UNIV WASHINGTON (6)· patent assignee history
2006–2017Based in Seattle, WA, US· patent location history
2010–2016Patents assigned to LIU ZHI-REN (6)· patent assignee history
2010–2020Based in Atlanta, GA, US· patent location history
2012–2020Patents assigned to UNIV GEORGIA STATE RES FOUND (7)· patent assignee history
2012–2015Patents assigned to LIU ZHI (3)· patent assignee history
2015–2019Based in Marietta, GA, US· patent location history
2017–2019Based in Shoreline, WA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV GEORGIA STATE RES FOUND72012–2020
LIU ZHI-RENself62010–2016
UNIV WASHINGTON62006–2017
LIU ZHIself32012–2015
UNIV BROWN RES FOUND32004–2013
Locations
LocationPatentsSpan
Seattle, Washington, US62006–2017
Atlanta, Georgia, US52010–2020
Shoreline, Washington, US22017–2019
Marietta, Georgia, US22015–2019
West Roxbury, Massachusetts, US22004